- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 70
Alentis accesses $67m series B
Morningside Venture Investments has led a series B round for the fibrotic diseases-focused spinout that advances University of Strasbourg research.
Jun 15, 2021HifiBio hits series D round with $75m
The cancer and autoimmune disease drug developer completed a Legend Star-backed series D round led by Mirae Asset Financial Group.
Jun 15, 2021Immersive Labs dips into $75m series C
The cybersecurity training platform developer has now raised a total of $123m as of the close of a Citi Ventures-backed round.
Jun 15, 2021Daily Deal Round Up: June 14, 2021
Online vehicle retailer Motorway, restaurant ordering software provider Popmenu and meat and fish e-commerce platform Licious have all raised between $65m and $68m.
Jun 14, 2021Senda enters details for $98m series B
Mayo Clinic and Alexandria Venture Investments contributed to a $55m extension that boosted the molecular drug developer's overall funding to $143m.
Jun 14, 2021Daily Deal Round Up: June 11, 2021
Transcarent has raised $58m from Bayer and Merck, while Nvidia has bought DeepMap, one of its portfolio companies also backed by Bosch.
Jun 11, 2021Baoyun Group bottles $94m in funding
The alcoholic beverage distributor's Country Garden-led series A round took its overall funding close to $157m.
Jun 11, 2021Daily Deal Round Up: June 10, 2021
Blockchain game developer Mythical Games pulled in $75m while enterprise software developer Morning Consult reached a unicorn valuation in an Advance Venture Partners-led round.
Jun 10, 2021Waabi warms up with series A round
Aurora and Uber are among the investors in the first publicly disclosed round for the self-driving software developer, which has raised $83.5m.
Jun 10, 2021Strateos straightens out series B funding
The GV and WuXi AppTec-backed operator of remote laboratory manager has secured $56.1m of new funding from investors including Eli Lilly.
Jun 10, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


